Immunoglobulin G - China Biologic Products

Drug Profile

Immunoglobulin G - China Biologic Products

Alternative Names: Human immunoglobulin; Human immunoglobulin 10%; Human immunoglobulin 5%; Immunoglobulin intravenous 10% - China Biologic Products; Immunoglobulin intravenous 5% - China Biologic Products; Intravenous immunoglobulin - China Biologic Products

Latest Information Update: 20 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator China Biologic Products
  • Class Immunoglobulin isotypes
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Immunodeficiency disorders

Most Recent Events

  • 25 Feb 2016 China Biologic Products receives approval for clinical trial by the CFDA (China Biologic Products, Form 10-K, February 2016)
  • 01 Jan 2014 Launched prior to 2014 for Immunodeficiency disorders in China (IV; 5% and 10%)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top